ENvue Medical, Inc. (FEED)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Noninvasive Biological Response-activating Devices	2.28M
Noninvasive Biological Response-activating Devices Growth	203.59%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	2.16M
United States Growth	204.51%
Europe	101.00K
Europe Growth	304.00%
Australia	19.00K
Australia Growth	111.11%
Israel	1,000.00